Scientific publications 2013

A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1.

Hum Mol Genet. 2013 Dec 20;22(25):5188-98. doi: 10.1093/hmg/ddt373. Epub 2013 Aug 6.

Gauthier M, Marteyn A, Denis JA, Cailleret M, Giraud-Triboult K, Aubert S, Lecuyer C, Marie J, Furling D, Vernet R, Yanguas C, Baldeschi C, Pietu G, Peschanski M, Martinat C.

 

Embryonic stem cells neural differentiation qualifies the role of Wnt/β-Catenin signals in human telencephalic specification and regionalization.

Stem Cells. 2013 Sep;31(9):1763-74. doi: 10.1002/stem.1462.

Nicoleau C, Varela C, Bonnefond C, Maury Y, Bugi A, Aubry L, Viegas P, Bourgois-Rocha F, Peschanski M, Perrier AL.

 

High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.

Stem Cells. 2013 Sep;31(9):1816-28. doi: 10.1002/stem.1430.

Charbord J, Poydenot P, Bonnefond C, Feyeux M, Casagrande F, Brinon B, Francelle L, Aurégan G, Guillermier M, Cailleret M, Viegas P, Nicoleau C, Martinat C, Brouillet E, Cattaneo E, Peschanski M, Lechuga M, Perrier AL.

 

Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesis.

Front Cell Neurosci. 2013 Aug 27;7:140. doi: 10.3389/fncel.2013.00140. eCollection 2013.

Benchoua A, Peschanski M.

 

Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening.

Transl Psychiatry. 2013 Aug 20;3:e294. doi: 10.1038/tp.2013.71.

Boissart C, Poulet A, Georges P, Darville H, Julita E, Delorme R, Bourgeron T, Peschanski M, Benchoua A

 

Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis.

Cell Reprogram. 2013 Jun;15(3):233-46. doi: 10.1089/cell.2012.0076. Epub 2013 May 10.

Lustremant C, Habeler W, Plancheron A, Goureau O, Grenot L, de la Grange P, Audo I, Nandrot EF, Monville C.

 

The multiple aspects of stroke and stem cell therapy.

Curr Mol Med. 2013 Jun;13(5):821-31.

Onteniente B.

 

Genetically-modified human pluripotent stem cells: new hopes for the understanding and the treatment of neurological diseases?

Curr Gene Ther. 2013 Apr;13(2):111-9. Review.

Nedelec S, Onteniente B, Peschanski M, Martinat C.

 

mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1.

J Cell Sci. 2013 Apr 15;126(Pt 8):1763-72. doi: 10.1242/jcs.116285. Epub 2013 Feb 26.

Denis JA, Gauthier M, Rachdi L, Aubert S, Giraud-Triboult K, Poydenot P, Benchoua A, Champon B, Maury Y, Baldeschi C, Scharfmann R, Piétu G, Peschanski M, Martinat C.